Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
企業コードMYO
会社名Myomo Inc
上場日Jun 12, 2017
最高経営責任者「CEO」Mr. Paul R. Gudonis
従業員数184
証券種類Ordinary Share
決算期末Jun 12
本社所在地137 Portland Street
都市BOSTON
証券取引所NYSE American Consolidated
国United States of America
郵便番号02114
電話番号16179969058
ウェブサイトhttps://myomo.com/
企業コードMYO
上場日Jun 12, 2017
最高経営責任者「CEO」Mr. Paul R. Gudonis
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし